NEO Projected Dividend Yield
NeoGenomics Inc ( NASDAQ : NEO )NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. Co. offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing, and comprehensive technical and professional services offering. Its Clinical Services customers include community-based pathology and oncology practices, hospital pathology labs, reference labs, and academic centers. 21 YEAR PERFORMANCE RESULTS |
NEO Dividend History Detail NEO Dividend News NEO Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |